Alan Fuhrman

2008 - OncoGenex Pharmaceuticals

In 2008, Alan Fuhrman earned a total compensation of $507.5K as Former Senior Vice President and Chief Financial Officer at OncoGenex Pharmaceuticals, a 93% increase compared to previous year.

Compensation breakdown

Option Awards$74,580
Salary$170,901
Other$262,049
Total$507,530

Fuhrman received $262K in other compensation, accounting for 52% of the total pay in 2008.

Fuhrman also received $74.6K in option awards and $170.9K in salary.

Rankings

In 2008, Alan Fuhrman's compensation ranked 6,456th out of 9,135 executives tracked by ExecPay. In other words, Fuhrman earned more than 29.3% of executives.

ClassificationRankingPercentile
All
6,456
out of 9,135
29th
Division
Manufacturing
2,392
out of 3,436
30th
Major group
Chemicals And Allied Products
528
out of 815
35th
Industry group
Drugs
359
out of 597
40th
Industry
In Vitro and In Vivo Diagnostic Substances
29
out of 51
43rd
Source: SEC filing on April 19, 2010.

Fuhrman's colleagues

We found four more compensation records of executives who worked with Alan Fuhrman at OncoGenex Pharmaceuticals in 2008.

2008

Michael Martino

OncoGenex Pharmaceuticals

Chief Executive Officer

2008

Scott Cormack

OncoGenex Pharmaceuticals

Chief Executive Officer

2008

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

2008

Stephen Anderson

OncoGenex Pharmaceuticals

Chief Financial Officer

News

You may also like